The ISREC Foundation is pleased to see the work performed by teams from the University of Geneva, the CHUV (Centre hospitalier universitaire vaudois) and the FBM UNIL (Faculty of Biology and Medicine of the University of Lausanne) published in Cell Reports.
Supported through our TANDEM program, this project opens new avenues to better understand T cell activity in immunooncology and illustrates the value of collaborations between basic and clinical research in promoting scientific progress. Congratulations to Dr. Benita Wolf, Dr. Virginie Hamel and all the teams involved.
For more information: An unprecedented view of the immune system’s killer cells – Medias – UNIGE
Warm congratulations to Prof. Susan M. Gasser on her election to the American Academy of Arts & Sciences.
This prestigious distinction honors an outstanding scientific career and a longstanding commitment to advancing research. We are proud to see our Director receive this recognition.
INVITATION
Projection : Espoir, vie et cancer
Mercredi 29 avril 2026 à 17h30
La Ligue vaudoise contre le cancer et la Fondation ISREC ont le plaisir de vous inviter à la projection du film documentaire « Tant qu’il y a de l’espoir, il y a de la vie », le mercredi 29 avril 2026 à AGORA, Lausanne.
Un moment fort autour de la vie avec le cancer, suivi d’un échange avec Diana, protagoniste du documentaire, la Dre Ana Dolcan, le Prof. Friedrich Stiefel, le Prof. Mikaël Pittet et la réalisatrice Jeanne Gerster, puis d’un apéritif.
Entrée libre, inscription obligatoire.
Informations, programme complet et inscription ici
We are delighted to congratulate Prof. Elisa Oricchio on her appointment as a full professor at the EPFL.
We are particularly proud to have contributed to the start of her career by supporting her tenure track chair, and to be witnessing the recognition of her professional development, commitment and research excellence.
Congratulations on this outstanding achievement!
For more information Three promotions in the Life Sciences – EPFL
A recent study conducted by Prof. Pittet’s research team has led to the identification of a key parameter of the immune system that can help predict poor outcomes in many types of cancer. Prof. Pittet’s chair is supported by the ISREC Foundation.
These findings enhance our understanding of the immune mechanisms at work in cancer and offer significant opportunities for translational research.
Congratulations to the entire research team for achieving this significant contribution.
To find out more, read the full article here: Ludwig Cancer Research
The ISREC Foundation wishes to congratulate Prof. Michele de Palma and Dr. Nahal Mansouri on their recent scientific publication highlighting promising advances in dendritic cell engineering and the stimulation of the anti-tumor immune response.
We are particularly proud to support these scientists’ research, dedicated to the development of novel cell therapy approaches for lung cancer.
Link to the project description: Small cell lung cancer – Prof. Michele de Palma (EPFL) and Dr. Nahal Mansouri (CHUV) – Fondation ISREC
Link to the scientific publication: https://lnkd.in/edZhthi8
Congratulations to Prof. Johanna Joyce, Prof. George Coukos, Prof. Raphael Gottardo, Prof. Olivier Michielin and Prof. Mikaël Pittet: according to the prestigious list published by Clarivate, they are among the most frequently cited scientists in 2025.
This distinction reflects the remarkable impact of their work, ranking in the top 1% of the most cited publications worldwide. It testifies to the important role of their research in the advancement of science and encourages new interdisciplinary collaborations.
On October 29, 2025, our annual conference combined science and laughter.
The first part of the event was devoted to the presentation of the 2025 TANDEM projects, which focus on digital pathology and are designed to advance research in line with clinical needs. Congratulations to these talented scientists on their ambition and the quality of their work.
And because a little lightheartedness goes a long way, Marie-Thérèse Porchet gave a delightfully quirky presentation… firmly standing by her views. She quickly won over the audience, leaving many in stitches: mission accomplished.
Many thanks to our community and our donors for their loyal support!
Let us continue to work together to turn ideas into results that benefit cancer patients.
2025 TANDEM grants: Fondation ISREC – TANDEM 2025 winners
Congratulations to Prof. Denis Migliorini, M.D., on his publication in “Nature Biomedical Engineering”, in which he describes novel therapeutic options in the fight against brain tumors. The ISREC Foundation is proud to support his Brain Tumor Immunology Chair and his research, which offers hope to many patients.
For more information: Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence | Nature Biomedical Engineering
Congratulations to Anaïs Golliet, winner of the ISREC Foundation’s Pierre-François Leyvraz Award 2025 for interprofessionality in oncology.
Anaïs Golliet receives this award for her project entitled “Analysis of the implementation of consultations by nursing professionals prior to the signing of a consent form for participation in an oncological clinical trial”.
This analysis of the implantation has been realized by Anaïs Golliet and Nour Al Akkachy, both of them from Masters in sciences infirmières at the IUFRS – Institut universitaire de formation et de recherche en soins à l’UNIL. Their work addresses the fundamental issues of information and informed consent in clinical trials, and stands out for its feasibility, clinical relevance and expected benefits for a large number of patients. It is part of a national initiative to promote autonomous consultations by nursing professionals.
This award was created by the ISREC Foundation in 2019 to honor the commitment of Professor Pierre-François Leyvraz, former Director General of the CHUV, to its Scientific Board. It recognizes projects carried out during training that promote the development of interprofessionality in the field of oncology.
Congratulations to Anaïs Golliet on this well-deserved recognition!
